Hepatic Pharmacology

In vivo and in vitro antiviral activity of hyperoside extracted from Abelmoschus manihot (L) medik



To assess the anti-hepatitis B virus (HBV) effect of hyperoside extracted from Abelmoschus manihot (L) medik.


The human hepatoma Hep G2.2.15 cell culture system and duck hepatitis B virus (DHBV) infection model were used as in vivo and in vitro models to evaluate the anti-HBV effects.


In the cell model, the 50% toxic concentration of hyperoside was 0.115 g/L; the maximum nontoxic concentration was 0.05 g/L. On the maximum nontoxic concentrations, the inhibition rates of hyperoside on HBeAg and HBsAg in the 2.2.15 cells were 86.41% and 82.27% on d 8, respectively. In the DHBV infection model, the DHBV-DNA levels decreased significantly in the treatment of 0.05 g- kg-1·d-1 and 0.10 g·kg-1·d-1 dosage groups of hyperoside (P<0.01). The inhibition of the peak of viremia was at the maximum at the dose of 0.10 g-kg-1·d-1 and reached 60.79% on d 10 and 69.78% on d 13, respectively.


These results suggested that hyperoside is a strong inhibitor of HBsAg and HBeAg secretion in 2.2.15 cells and DHBV-DNA levels in the HBV-infected duck model.


  1. 1

    Bourdy G, Walter A . Maternity and medicinal plants in Vanuatu. I. The cycle of reproduction. J Ethnopharmacol 1992; 37: 179–96.

  2. 2

    . Preston SR . Aibika/Bele-Abelmoschus manihot (L.) Medik. In: CAB ABSTRACTS. CAB International. 1998. p97.

  3. 3

    . Puel C, Mathey J, Kati-Coulibaly S, Davicco M J, Lebecque P, Chanteranne B, et al. Preventive effect of Abelmoschus manihot (L.) Medik on bone loss in the ovariectomised rats. J Ethnopharmacol 2005; 99: 55–60.

  4. 4

    . Ye M, Li Y, Yan Y, Liu H, Ji X . Determination of flavonoids in Semen Cuscutae by RP-HPLC. J Pharm Biomed Anal 2002; 28: 621–8.

  5. 5

    . Pietta P, Gardana C, Pietta A . Comparative evaluation of St. John's wort from different Italian regions. IL Farmaco 2001; 56: 491–6.

  6. 6

    . Sloley BD, Urichuk LJ, Ling L, Gu LD, Coutts RT, Pang PK, et al. Chemical and pharmacological evaluation of Hpericum perforatum extracts. Acta Pharmacol Sin 2000; 21: 1145–52.

  7. 7

    . Zhang Z, Chang Q, Zhu M, Huang Y, Ho WK, Chen Z . Characterization of antioxidants present in hawthorn fruits. J Nutr Biochem 2001; 12: 144–52.

  8. 8

    . Mino J, Acevedo C, Moscatelli V, Ferraro G, Hnatyszyn O . Antinociceptive effect of the aqueous extract of Balbisia calycina. J Ethnopharmacol 2002; 79: 179–82.

  9. 9

    . Manga HM, Brkic D, Marie DE, Quetin-Leclercq J . In vivo anti-inflammatory activity of Alchornea cordifolia (Schumach & Thonn.) Mull Arg (Euphorbiaceae). J Ethnopharmacol 2004; 92: 209–14.

  10. 10

    Shahat AA, Pieters L, Apers S, Nazeif NM, Abdel-Azim NS, Berghe DV, et al. Chemical and Biological Investigations on Zizyphus spina-christi L. Phytother Res 2001; 15: 593–7.

  11. 11

    Shi Y, Shi RB, Liu B . Studies on antiviral flavonoids in Yinqiaosan Powder. Chin J Chin Mat Med 2001; 26: 320–2. Chinese.

  12. 12

    Chen ZW, Ma CG, Fang M . Mechanism of analgesic action of hyperin. Acta Pharm Sin 1989; 24: 226–30. Chinese.

  13. 13

    Ma CG, Xiang ZM, Xu SY . Mechanism of analgesic action of hyperin on centrum. Chin Pharmacol Bull 1991; 7: 345–9. Chinese.

  14. 14

    Zhang JS, Chen ZW, Wang Y, Song BW, Dong LY, Cen DY . Mechanism of analgesic action of hyperin on spinal cord. Anhui Med 1998; 19: 3–5. Chinese.

  15. 15

    Lee SJ, Son KH, Chang HW, Do JC, Jung KY, Kang SS . Anti-inflammatory activity of naturally occurring flavone and flavonol glycosides. Arch Pharm Res 1992; 16: 25–8.

  16. 16

    Li QL, Yu GX, Chen Z, Ma CG . Inhibitory mechanism of hyperin of the apoptosis in myocardial ischemia/reperfusion in rats. Acta Pharm Sin 2002; 37: 849–52. Chinese.

  17. 17

    Wang WQ, Ma CG, Xu SY . Protective effect of hyperin against myocardial ischemia and reperfusion injury. Acta Pharmacol Sin 1996; 17: 341–4.

  18. 18

    Xiong, Q, Fan, W, Tezuka, Y Adnyana, IK, Stampoulis, P, Hattori, M, et al. Hepatoprotective effect of Apocynum venetum and its active constituents. Planta Medica 2000; 66: 127–33.

  19. 19

    Carlo GD, Mascolo N, Izzo AA, Capasso F . Flavonoids: old and new aspects of a class of natural therapeutic drugs. Life Sci 1999; 65: 337–53.

  20. 20

    Ito M, Shimura H, Watanaba N, Tamai M, Hanada K, Takahashi A, et al. Hepatoprotective compounds from Canarium album and Euphorbia nematocypha. Chem Pharm Bull (Tokyo) 1990; 38: 2201–3.

  21. 21

    Zhao WZ, Chen ZW, Song BW . Wang YL, Wang Q, Fang M, et al. The protective effect of hyperin on gastric mucosal injury in mice and its mechanism. Acta Anhui Med Univ 1999; 3: 178–80.

  22. 22

    Song BW, Chen ZW, Ma CG . The cell protective effect of hyperin on gastric mucosal injury in rats. Chin Pharmacol Bull 1995; 11 Suppl: 46–8. Chinese.

  23. 23

    Kane M . Global programme for control of hepatitis B infection. Vaccine 1995; 13 Suppl 1: S47–9.

  24. 24

    Liaw YF, Leung NW, Chang TT, Guan R, Tai DI, Ng KY, et al. Effects of extended lamivudine therapy in Asian patients with chronic hepatitis B. Gastroenterol 2000, 119: 172–80.

  25. 25

    Leung NW, Lai CL, Chang TT, Guan R, Lee CM, Ng KY, et al. Extented lamivudine treatment in patients with chronic hepatitis B enhances hepatitis B e antigen seroconversion rates: results after 3 years of therapy. Hepatology 2001; 33: 1527–32.

  26. 26

    Shin MS, Kang EH, Lee YI . A flavonoid from medicinal plants blocks hepatitis B virus-e antigen secretion in HBV-infected hepatocytes. Antivir Res 2005; 67: 163–8.

  27. 27

    Bradham CA, Plumpe J, Manns MP, Brenner DA, Trautwein C . Mechanisms of hepatic toxicity I. TNF-induced liver injury. Am J Physiol 1998; 275: G387–92.

  28. 28

    Lam WY, Leung KT, Law PT, Lee SM, Chan HL, Fung KP, et al. Antiviral effect of phyllanthus nanus ethanolic extract against Hepatitis B virus (HBV) by expression microarray analysis. J Cell Biochem 2006; 97: 795–812.

Download references

Author information

Correspondence to Xin-bo Yang or Zheng-ming Huang.

Additional information

Project supported by the National Natural Science Foundation of China (No 30572350, 30170994).

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Wu, L., Yang, X., Huang, Z. et al. In vivo and in vitro antiviral activity of hyperoside extracted from Abelmoschus manihot (L) medik. Acta Pharmacol Sin 28, 404–409 (2007) doi:10.1111/j.1745-7254.2007.00510.x

Download citation


  • hyperoside
  • hepatitis B virus
  • duck hepatitis B virus
  • antiviral agents

Further reading